Tao, Wei
Harvard Medical School,
United States
2025 Rank: 10261
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 346 out of 156020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10261 | 10952 |
| Total Cites | 4741 | 5034 |
| H-index | 38 | 40 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 269 | 284 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 2246 | 2388 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3738 | 3845 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.31 |
| Self-Citation Percentage |
5.82%
|
|
Tao, Wei
Harvard Medical School,
United States
2024 Rank: 12071
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 372 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12071 | 11643 |
| Total Cites | 3860 | 4265 |
| H-index | 34 | 37 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 316 | 348 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 1663 | 1868 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2871 | 2976 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.43 |
| Self-Citation Percentage |
9.50%
|
|
Tao, Wei
Harvard Medical School,
United States
2023 Rank: 15245
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 452 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15245 | 14196 |
| Total Cites | 3458 | 3941 |
| H-index | 33 | 35 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 348 | 412 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 1216 | 1446 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2558 | 2694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.46 |
| Self-Citation Percentage |
12.26%
|
|
Tao, Wei
Harvard Medical School,
United States
2022 Rank: 21631
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 596 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21631 | 19357 |
| Total Cites | 2773 | 3282 |
| H-index | 29 | 30 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 395 | 544 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 850 | 1132 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2028 | 2147 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.53 |
| Self-Citation Percentage |
15.51%
|
|
Tao, Wei
Harvard Medical School,
United States
2021 Rank: 27474
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 679 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27474 | 27797 |
| Total Cites | 3867 | 4260 |
| H-index | 34 | 36 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 818 | 924 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 1087 | 1258 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2759 | 2867 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.49 |
| Self-Citation Percentage |
9.23%
|
|
Tao, Wei
Harvard Medical School,
United States
2020 Rank: 45307
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1244 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45307 | 42743 |
| Total Cites | 2091 | 2416 |
| H-index | 26 | 27 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 387 | 508 |
| Number of Single+First+Last Authored Papers | 12 | 12 |
| Total Cites to Single+First+Last Authored Papers | 398 | 523 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1560 | 1676 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
13.45%
|
|